Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide derivative Cerebrolysin®

  • B. Hutter-Paier
  • E. Grygar
  • M. Windisch
Part of the Journal of Neural Transmission Supplement book series (NEURAL SUPPL, volume 47)


Glutamate induced neurotoxicity has been proposed to account for the loss of neurons after ischemia as well as in the cause of neurodegenerative diseases. We have studied the effects of exogenous glutamate on survival of neurons from chick embryo telencephalon, precultured with a peptide derivative for 8 days. The peptide derivative Cerebrolysin® is a drug produced by standardised enzymatic breakdown consisting of 80% peptides and 20% amino acids. Toxic effects of acute glutamate exposure were prevented by Cerebrolysin in a concentration-dependent manner. 20 and 40µl Cerebrolysin produce distinct neuroprotective effects. However, 80µ1 Cerebrolysin/ml nutrition medium more than doubles neuronal viability compared to untreated control cells. These concentration-dependent effects of Cerebrolysin were evident even at the light microscopic level.


Amyotrophic Lateral Sclerosis NMDA Receptor Nutrition Medium Peptide Derivative Peptide Growth Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barde A (1989) Trophic factors and neuronal survival. Neuron 2: 1525–1534PubMedCrossRefGoogle Scholar
  2. Choi DW (1987) Ionic dependence of glutamate neurotoxicity. J Neurosci 7: 369–379PubMedGoogle Scholar
  3. Choi DW (1990) Methods for antagonising glutamate neurotoxicity. Cerebrovasc Brain Metab Rev 2: 105–147PubMedGoogle Scholar
  4. Choi DW, Koh JY, Peters S (1988) Pharmacology of glutamate neurotoxicity in cortical culture: attenuation by NMDA antagonists. J Neurosci 8: 185–196PubMedGoogle Scholar
  5. Drian MJ, Kamenka JM, Pirat JL, Privat A (1991) Non-competitive antagonist of Nmethyl-D-aspartate prevent spontaneous neuronal death in primary cultures of embryonic rat cortex. J Neurosci Res 29: 133–138PubMedCrossRefGoogle Scholar
  6. Greenamyre JT (1986) The role of glutamate in neurotransmission and neurologic disease. Arch Neurol 43: 1058–1063PubMedCrossRefGoogle Scholar
  7. Gschanes A, Windisch M, Bures J (1993) Cerebrolysin, a peptidergic drug increases performance of ischemic rats in the Morris water maze. Eur J Neurosci [Suppl 6]: 140Google Scholar
  8. Lauritzen M, Hansen AJ (1992) The effect of glutamate receptor blockade on anoxic depolarisation and cortical spreding depression. J Cereb Blood Flow Metab 12: 223–229PubMedCrossRefGoogle Scholar
  9. Maragos WF, Greenamyre JT, Penny JB, Young AB (1987) Glutamate dysfunction in Alzheimer’s disease: a hypothesis. Trends Neurosci 10: 65–68CrossRefGoogle Scholar
  10. Matteson MP, Murrain M, Guthrie PB, Kater SB (1989) Fibroblast growth factor and glutamate: opposing action in the generation and degeneration of hippocampal neuroarcitecuture. J Neurosci 9: 3728–3740Google Scholar
  11. Meldrum B, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11: 379–387PubMedCrossRefGoogle Scholar
  12. Morris RGM (1989) Synaptic plasticity and learning: selective impairment of learning in rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. J Neurosci 9: 3040–3057PubMedGoogle Scholar
  13. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 65: 55–63PubMedCrossRefGoogle Scholar
  14. Olney J, Price M, Salles KS, Labruyere J, Friedrich G (1987) MK-801 powerfully protects against N-methyl-D-aspartate neurotoxicity. Eur J Pharmacol 141: 357–361PubMedCrossRefGoogle Scholar
  15. Paier B, Windisch M, Eggenreich U (1992) Postnatal administration of two peptide mixture affects passive avoidance behaviour of young rats. Behav Brain Res 51: 23–28PubMedCrossRefGoogle Scholar
  16. Pettmann B, Louis JC, Sensenbrenner LM (1979) Morphological and biochemical maturation of neurons cultured in the absence of glia cells. Nature 281: 378–380PubMedCrossRefGoogle Scholar
  17. Piswanger A, Paier B, Windisch M (1990) Modulation of protein synthesis in a cell free system from rat brain by Cerebrolysin during development and ageing. In: Lubec G, Rosenthal GA (eds) Amino acids. Escom Sciences Publishers B.V., Leiden, pp 651–657CrossRefGoogle Scholar
  18. Plaitakis A, Caroscio JT (1987) Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 22: 575–579PubMedCrossRefGoogle Scholar
  19. Prehn JHM, Peruche B, Unsicker K, Krieglstein J (1993) Isoform-specific effects of transforming growth factors-(3 on degeneration of primary cultures induced by cytotoxic hypoxia or glutamate. J Neurochem 60: 1665–1672PubMedCrossRefGoogle Scholar
  20. Roberts AB, Sporn MB (1990) The transforming growth factors-ft In: Sporn MB, Roberts AB (eds) Handbook of experimental pharmacology, peptide growth factors and their receptors. Springer, Berlin Heidelberg New York Tokyo, pp 419–472Google Scholar
  21. Rüther E, Ritter R, Apecechea M, Freytag S, Windisch M (1993) Efficacy of the peptidergic drug Cerebrolysin in patients with senile dementia of the Alzheimer’s type ( SDAT ). Pharmacopsychiatry 27: 32–37CrossRefGoogle Scholar
  22. Skaper SD, Leon A, Facci L (1991) Ganglioside GM1 prevents death induced by excessive excitatory neurotransmission in cultured hippocampal pyramidal neurons. Neurosci Lett 117: 154–159CrossRefGoogle Scholar
  23. Thoenen H, Bantlow C, Heumann R (1987) The physiological function of nerve growth factor in the central nervous system: comparison with periphery. Rev Physiol Biochem Pharmacol 109: 145–178PubMedCrossRefGoogle Scholar
  24. Windisch M, Gschanes A, Valouskova V (1993) The effects of different growth factors in rats after lesion of the somatosensory cortex. Eur J Neurosci [Suppl 6]: 140Google Scholar
  25. Xiong H, Wojtowicz JM, Baskys A (1995) Brain tissue hydrolysate acts on presynaptic adenosine receptors in the rat hippocampus. Can J Physiol Pharmacol 73: 1194–1197PubMedCrossRefGoogle Scholar
  26. Young AB, Greenamyre JT, Hollingsworth Z, Albin R, D’Amato C, Shoulson I, Penny JB (1988) NMDA receptor losses in putamen from patients with Huntington’s disease. Science 241: 981–983PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • B. Hutter-Paier
    • 1
  • E. Grygar
    • 1
  • M. Windisch
    • 1
  1. 1.Center of Animal Biology, Medical SchoolUniversity of GrazGrazAustria

Personalised recommendations